GI
KURA icon

GAMMA Investing’s Kura Oncology KURA Stock Holding History

GAMMA Investing’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14.6K Buy
1,327
+540
+69% +$5.09K ﹤0.01% 3017
2026
Q1 		$6.4K Buy
787
+330
+72% +$2.83K ﹤0.01% 3270
2025
Q4 		$4.75K Buy
457
+340
+291% +$3.57K ﹤0.01% 3299
2025
Q3 		$1.03K Sell
117
-60
-34% -$428 ﹤0.01% 3608
2025
Q2 		$1.02K Sell
177
-204
-54% -$1.25K ﹤0.01% 3534
2025
Q1 		$2.52K Sell
381
-212
-36% -$1.65K ﹤0.01% 3344
2024
Q4 		$5.17K Buy
593
+61
+11% +$878 ﹤0.01% 2908
2024
Q3 		$10.4K Hold
532
– – ﹤0.01% 2441
2024
Q2 		$11K Sell
532
-19
-3% -$391 ﹤0.01% 2203
2024
Q1 		$11.8K Buy
551
+56
+11% +$1.09K ﹤0.01% 1973
2023
Q4 		$9.97K Buy
+495
New +$4.87K ﹤0.01% 1903

Other funds holding KURA

HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
AWA
Aaron Wealth Advisors Chicago, Illinois $1.97B AUM 36.91% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
NAM
NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return
FCC
Flower City Capital Pittsford, New York $227M AUM 23.31% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GAMMA Investing's KURA Position: Q2 2026 in Review

GAMMA Investing increased its Kura Oncology (KURA) stake by 69% in Q2 2026, buying an estimated $5.09K and bringing the position to 1,327 shares worth $14.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3017.

GAMMA Investing first reported a position in KURA in Q4 2023 and has held it in 11 quarters since. 25 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • GAMMA Investing held 1,327 shares of Kura Oncology worth $14.6K as of Q2 2026.
  • GAMMA Investing bought 540 Kura Oncology shares in Q2 2026, an estimated $5.09K.
  • Kura Oncology made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3017 holding.
  • GAMMA Investing first reported a position in Kura Oncology in Q4 2023 and has held it in 11 quarters since.
  • 25 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.